UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000052781
Receipt number R000060228
Scientific Title Survey on Actual Clinical Practice for Infantile Atopic Dermatitis
Date of disclosure of the study information 2023/11/13
Last modified on 2023/11/13 12:25:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Survey on Actual Clinical Practice for Infantile Atopic Dermatitis

Acronym

Survey on Actual Clinical Practice for Infantile Atopic Dermatitis

Scientific Title

Survey on Actual Clinical Practice for Infantile Atopic Dermatitis

Scientific Title:Acronym

Survey on Actual Clinical Practice for Infantile Atopic Dermatitis

Region

Japan


Condition

Condition

Infantile Atopic Dermatitis

Classification by specialty

Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To grasp the actual clinical practice of infantile atopic dermatitis and the reason leading to the clinical practice among pediatricians at institutions with 19 beds or less

Basic objectives2

Others

Basic objectives -Others

Cross-sectional Study by Questionnaire Survey

Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase

Phase IV


Assessment

Primary outcomes

Grasp of the current situation of diagnosis
Grasp of the current situation of treatment
Physician's recognition

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Physicians who meet all of the following inclusion criteria will be included in this study.
1.Pediatricians working at institutions with 19 beds or less
2.Those who responded that they examined 10 or more infants aged 0 years in the most recent 1 month
3.Those who responded that they examine infantile eczema and/or atopic dermatitis in daily clinical practice
4.Those who agree to participate in the survey

Key exclusion criteria

There are no exclusion criteria.

Target sample size

240


Research contact person

Name of lead principal investigator

1st name Kana
Middle name
Last name Okamoto

Organization

Otsuka Pharmaceutical Co., Ltd.

Division name

Medical Affairs

Zip code

108-8242

Address

Shinagawa Grand Central Tower, 2-16-4 Konan, Minato-ku, Tokyo, Japan

TEL

03-6717-1400

Email

Okamoto.Kana@otsuka.jp


Public contact

Name of contact person

1st name Tomoyuki
Middle name
Last name Kusaka

Organization

Social Survey Research Information Co., Ltd.

Division name

Healthcare BI & MA Service Division Health Outcomes Research

Zip code

162-0067

Address

NMF Shinjuku EAST Bldg., 10-5 Tomihisacho, Shinjuku-ku, Tokyo, Japan

TEL

03-6709-9710

Homepage URL


Email

HOR@ssri.com


Sponsor or person

Institute

Otsuka Pharmaceutical Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Otsuka Pharmaceutical Co., Ltd.

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Medical Corporation TOUKEIKAI Kitamachi Clinic ERB

Address

1-1-3, Kichijoji-kitamachi, Musashino-shi, Tokyo, Japan

Tel

03-6779-8166

Email

chi-pr-ec-kitamachi@cmicgroup.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 11 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2023 Year 09 Month 29 Day

Date of IRB


Anticipated trial start date

2023 Year 10 Month 27 Day

Last follow-up date

2023 Year 11 Month 26 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

To grasp the actual clinical practice of infantile atopic dermatitis and the reason leading to the clinical practice among pediatricians at institutions with 19 beds or less


Management information

Registered date

2023 Year 11 Month 13 Day

Last modified on

2023 Year 11 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000060228


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name